Ophthalmologic Drug Guide - Rhee, Douglas J.; Colby, Kathryn A.; Sobrin, Lucia; Rapuano, Christopher J.
55,99 €
versandkostenfrei*

inkl. MwSt.
Sofort lieferbar
28 °P sammeln

    Broschiertes Buch

The updated second edition of this popular pocket guide includes newly available and FDA-approved drugs as well as guidance on using the growing number of drugs now prescribed for off-label purposes, such as anti-VEGF agents used in cancer treatments.
Drug therapy as an alternative to surgical intervention is becoming increasingly common. In the past five years, new anti-glaucoma agents have becoming increasingly effective. This edition will include new information on off-label prescribing and cap colors where they are mandated by the FDA (pink/white for steroid drops, grey for topical…mehr

Produktbeschreibung
The updated second edition of this popular pocket guide includes newly available and FDA-approved drugs as well as guidance on using the growing number of drugs now prescribed for off-label purposes, such as anti-VEGF agents used in cancer treatments.
Drug therapy as an alternative to surgical intervention is becoming increasingly common. In the past five years, new anti-glaucoma agents have becoming increasingly effective. This edition will include new information on off-label prescribing and cap colors where they are mandated by the FDA (pink/white for steroid drops, grey for topical NSAIDS, etc.) There are now several new pharmaceutical agents being used to treat retinal diseases such as age-related macular degeneration (Macugen, Lucentis, Visudyne), while other drugs formerly prescribed have now been shown to be less effective. Intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets continue to grow, with a new formulation of Allergan's Acular 0.5% (ketorolac tromethamine) and Elestat ophthalmic solution, its new antihistamine-mast cell stabilizer.
  • Produktdetails
  • Verlag: Springer, Berlin
  • Artikelnr. des Verlages: 12678235
  • 2nd ed.
  • Erscheinungstermin: Januar 2011
  • Englisch
  • Abmessung: 204mm x 128mm x 13mm
  • Gewicht: 168g
  • ISBN-13: 9781441976208
  • ISBN-10: 1441976205
  • Artikelnr.: 31085540
Autorenporträt
Douglas J. Rhee, MD Assistant Professor Harvard Medical School Associate Chief, Practice Development Massachusetts Eye & Ear Infirmary Boston, Massachusetts USA Katheryn A. Colby, MD, PhD Assistant Professor Harvard Medical School Cornea Service Massachusetts Eye & Ear Infirmary Boston, Massachusetts USA Christopher J. Rapuano, MD Professor Jefferson Medical College Director, Cornea Service Wills Eye Hospital Philadelphia, Pennsylvania USA Lucia Sobrin, MD, MPH Assistant Professor Harvard Medical School Massachusetts Eye & Ear Infirmary Boston, Massachusetts USA
Inhaltsangabe
Antibacterial Agents.- Antifungal Agents.- Antiviral Agents.- Antiparasitic Agents.- Antiglaucoma Agents.- Neuro-ophthalmology.- Retina.- Antiinflammatory Agents.- Mydriatics, Cycloplegics, and Reversal Agents.- Lubricants and Viscoelastics.- Miscellaneous (Appendices) Topical Antibacterial Spectrum.- Preparing Fortified Topical Antibiotics and Oral Acetazolamide Solution.- Antifungal Activity Spectrum.- Renal Dosing for Selected Drugs.- Glaucoma Medication Preservatives.- Product Index.- Subject Index.